Cyclo Therapeutics, Inc. - Common Stock (NQ:CYTH)

0.7206 UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cyclo Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Cyclo Therapeutics to Present at 8th Annual Dawson James Conference

October 05, 2023

From Cyclo Therapeutics, Inc.

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Intercept Pharmaceuticals, Inc. (Nasdaq – ICPT), Splunk, Inc. (Nasdaq – SPLK), Applied Molecular Transport Inc. (Nasdaq - AMTI), NextGen Healthcare, Inc. (Nasdaq –

September 26, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023 ↗

September 27, 2023

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Splunk, Inc. (Nasdaq – SPLK), Applied Molecular Transport Inc. (Nasdaq - AMTI), NextGen Healthcare, Inc. (Nasdaq – NXGN), Computer Task Group, Incorporated (Nasdaq -

September 21, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

September 21, 2023

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday.

Via Benzinga

Rare Disease Player Cyclo Therapeutics To Merge With Applied Molecular Transport ↗

September 21, 2023

Applied Molecular Transport Inc (NASDAQ: AMTI) has agreed to merge with Cyclo Therapeutics Inc (NASDAQ: CYTH) in an

Via Benzinga

CYTH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Cyclo Therapeutics, Inc. Is Fair to Shareholders

September 21, 2023

From Halper Sadeh LLC

Via Business Wire

Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement

September 21, 2023

From Cyclo Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 08, 2023

Via Benzinga

Cyclo Therapeutics Reports Second Quarter 2023 Financial Results

August 15, 2023

From Cyclo Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

August 03, 2023

Via Benzinga

Cyclo Therapeutics And This Other Penny Stock Insiders Are Buying ↗

August 03, 2023

The Dow Jones closed lower by around 350 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 02, 2023

Via Benzinga

Cyclo Therapeutics Announces Closing of $5.0 Million Private Placement with Rafael Holdings, Inc.

August 02, 2023

From Cyclo Therapeutics, Inc.

Via Business Wire

Cyclo Therapeutics Announces Publication of Positive Data from Phase 2 Clinical Study of Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C1

June 29, 2023

From Cyclo Therapeutics, Inc.

Via Business Wire

Why Inventiva Shares Are Trading Higher By 24%; Here Are 20 Stocks Moving Premarket ↗

June 14, 2023

Gainers Cyxtera Technologies, Inc. (NASDAQ: CYXT) shares rose 134.6% to $0.0981 in pre-market trading after dropping 12% on Tuesday.

Via Benzinga

Rafael Holdings Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Update

June 13, 2023

Since the end of the third quarter, we made an initial $2.1 million investment in Cyclo Therapeutics, Inc. (Nasdaq: CYTH) and have an agreement to increase our investment by $5 million

From Rafael Holdings, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 12, 2023

Via Benzinga

Cyclo Therapeutics Announces Allowance of Patent from European Patent Office for Trappsol® Cyclo™ for Alzheimer’s Disease

June 12, 2023

From Cyclo Therapeutics, Inc.

Via Business Wire

Cyclo Therapeutics Announces Execution of Definitive Agreement with Rafael Holdings, Inc. Providing for $5.0 Million of Additional Funding Via a Private Placement

June 05, 2023

From Cyclo Therapeutics, Inc.

Via Business Wire

Cyclo Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results

May 15, 2023

From Cyclo Therapeutics, Inc.

Via Business Wire

Cyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL)

May 02, 2023

From Cyclo Therapeutics, Inc.

Via Business Wire

Why Bed Bath & Beyond Shares Are Trading Lower By 23%; Here Are 20 Stocks Moving Premarket ↗

April 26, 2023

Gainers

Via Benzinga

Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 25, 2023

Gainers

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 21, 2023

Via Benzinga

Cyclo Therapeutics Announces Closing of $1.3 Million Private Placement Priced At-The-Market Under Nasdaq Rules

April 21, 2023

From Cyclo Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 12, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

April 07, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

April 03, 2023

On Monday, 76 companies set new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023 ↗

March 21, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.